Daniel Furlin

CRA experience: Cardiology, Rare deseases, Oncology and Pneumology Visits: SSV, Initiation, IMV (On and Offsite) and COV.

CRA experience: Cardiology, Endocrinology, Rare deseases and Oncology; Visits: Initiation, IMV (On and Offsite) and COV.

CRA experience: Cardiology and Endocrinology; Visits: Initiation, IMV (On and Offsite) and COV.

Responsible for researching, purchasing, receiving, and exporting material needs (antibodies, cells, chemicals, solutions and equipment) of clinical research professionals in University and Hospital based facilities in Brazil. http://www.tfsconsultants.us

CRA experience: Cardiology, Endocrinology, Nefrology and Urology. DDCM; Feasibility; CDA; Visits: Site Selection, Initiation, IMV and COV; Making of IMPs.

Studies in which he participated: Oncology 1 - International Studies Phase III First-Line for Follicular Lymphoma. Cardiology 1 - International Study Phase III Pediatric, to Evaluate Hypertension With or Without Chronic Disease; 2 - International Studies Phase III, of major Cardiovascular Events in subjects High Risk. Nephrology 2 - International Studies Phase III Pediatric, to Evaluate Overactive Bladder; 1 - International Study Phase III Pediatric, to Assess the Hyperactivity Neurogenic Detrusor; 1 - International Study Phase III, Diabetes Mellitus Type II and Diabetic Nephropathy; Infectology 1 - International Study Phase III, Uncomplicated Influenza; 1 - National Study Phase IV, Control of Symptoms of Cooled and Influenza; 1 - National Study Phase III, Nasal congestion and nasal dripping Gifts in Crisis Acute Viral Rhinitis; 1 - National Study Phase III, Control of Symptoms of Perennial Allergic Rhinitis. Gynecology 1 - National Study Phase IV, Post Operative of Cesarean Surgery; Orthopedics 1 - National Study Phase III, Acute Traumatic Injuries. Urology 1 - International Study Phase III, Treatment of Complicated Urinary Tract Infection, Including Pyelonephritis Acute (PA) in Adults. Ophthalmology 1 - National Study Phase IV, Post Operative of Cesarean Surgery. Endocrinology 1 - National Study Phase III, Deficiency Growth Hormone; 1 - International Observational Study, Treatment of Type II Diabetes in the Real World. Rheumatology 1 - International Study Phase IIIB/IV, Rheumatoid Arthritis. Safety 1 - National Study Phase III, Acute Bacterial Tonsilitis.

Studies in which he participated: 1 International Study Phase II, Advanced or Metastatic Basal Cell Carcinoma; 1 International Study Phase III, LLC to First Line; 1 International Study Phase III, LLC for Maintenance; 1 International Study Phase III First-Line for Follicular Lymphoma;. 1 National Study Phase II, First Line for Metastatic Prostate Cancer; 1 National Observational Study to HER Status in Patients with Breast Cancer; 1 International Study Phase II, Second Line for Kidney Cancer; 2 International Studies Phase III, Second-Line Metastatic Sarcoma; 1 International Study Phase III, First-Line Metastatic Sarcoma to Pediatric; 1 International Study Phase IIIb, Second Line for Follicular Lymphoma; 1 International Study Phase I, for Follicular Lymphoma - Therapy Maintenance; 1 International Study Phase III, Second Line for Follicular Lymphoma; 1 Study International Compassionate - Hodgkin Lymphoma Second Line; 1 International Study Expanded - Melanoma - (Second or Third Line ); 1 International Study Phase III, Second or Third Line for Pediatric Osteosarcoma; 1 International Srudy Phase III, Transplant Recipients - Prophylactic for Herpes Zoster; 1 International Study Phase III, Solid Tumors - Prophylactic for Herpes Zoster; 1 Study Pharmacoeconomics; 1 International Study Phase IIb, Assessment of Pharmacokinetics and Pharmacodynamics Pediatric Prevention of Nausea and Vomiting.

Expression in E. coli of Rlosac (Activator A Fx) of Lonomia poison Expressed in Cell Culture Media induced Rlosac.